Pharmacokinetic, Safety, and Tolerability Study of Intranasally Administered Esketamine in Elderly Japanese, and Healthy Younger Adult Japanese Subjects
PHASE1
The purpose of this study is to compare the pharmacokinetics, safety, and t...
Study to Evaluate the Efficacy and Safety of 3 Fixed Doses of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Pediatric Participants Assessed to be at Imminent Risk for Suicide
PHASE2
The purpose of this study is to assess the efficacy of a single (first) dos...
Crossover Study to Evaluate the Abuse Potential of Intranasal Esketamine Compared to Racemic Intravenous Ketamine in Nondependent, Recreational Drug Users
PHASE1
The primary objective of this study is to evaluate the abuse potential of i...
An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives
PHASE3
The purpose of this expanded access program (EAP) is to provide expanded ac...
Status
Completed
Location
Clínica de Ansiedad, Depresión y Estrés CADE, S. de R.L. de C.V.